NASDAQ : ABEO

Abeona Therapeutics Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 4.35 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 248.75M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Abeona Therapeutics Inc. (ABEO) reported revenue of 25.52M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue25.52M5.82M3.50M1.41M3.00M
Cost of Revenue35.70M30.24M34.36M32.70M29.41M38.73M
Gross Profit-10.18M-24.42M-34.36M-29.20M-28.00M-35.73M
Selling, General & Admin73.43M65.03M29.85M19.00M17.26M21.64M
Operating Expenses73.43M65.03M29.85M19.00M17.26M21.64M
Operating Income-83.61M-89.45M-64.21M-48.20M-45.26M-57.37M
Interest Expense-3.31M-3.74M-4.21M-418.00K-736.00K-3.66M
Interest & Investment Income5.93M5.56M4.25M2.12M431.00K40.00K
Other Non Operating Income (Expenses)2.70M6.55M437.00K-8.71M11.66M15.00K
EBT Excluding Unusual Items-78.30M-81.08M-63.74M-55.21M-33.90M-60.97M
Impairment of Goodwill-32.47M
Gain (Loss) on Sale of Assets152.37M2.00K-47.00K-138.00K
Asset Writedown1.06M-5.66M
Other Unusual Items8.50M
Pretax Income-78.30M71.28M-63.73M-54.19M-39.70M-84.94M
Income Tax Expense-15.41M100.00K
Net Income-62.89M71.18M-63.73M-54.19M-39.70M-84.94M
Preferred Dividends & Other Adjustments3.78M
Net Income to Common-62.89M71.18M-63.73M-54.19M-43.48M-84.94M
Shares Outstanding (Basic)55.79M52.95M41.05M21.38M7.86M3.94M
Shares Outstanding (Diluted)55.79M66.14M41.05M21.38M7.86M3.94M
EPS (Basic)-1.131.34-1.55-2.53-5.53-21.57
EPS (Diluted)-1.181.01-1.55-2.53-5.53-21.57
Free Cash Flow-81.53M-84.30M-58.46M-37.34M-43.61M-69.82M
Free Cash Flow Per Share-1.46-1.27-1.42-1.75-5.55-17.73
Gross Margin-39.90%
Operating Margin-327.64%-1,536.91%-1,377.14%-3,200.64%-1,912.33%
Profit Margin-246.42%1,223.08%-1,548.23%-3,074.82%-2,831.20%
Free Cash Flow Margin-319.46%-1,448.47%-1,066.86%-3,084.37%-2,327.20%
EBITDA-80.79M-86.90M-62.21M-45.91M-42.16M-54.12M
D&A For EBITDA2.83M2.55M2.00M2.29M3.09M3.25M
EBIT-83.61M-89.45M-64.21M-48.20M-45.26M-57.37M
Effective Tax Rate0.14%
Revenue as Reported25.52M5.82M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents56.23M78.44M23.36M14.47M14.22M32.94M
Short-Term Investments90.60M112.97M74.36M37.75M37.93M12.09M
Cash & Short-Term Investments146.83M191.40M97.72M52.23M52.15M45.02M
Accounts Receivable9.39M6.15M3.00M
Other Receivables495.00K568.00K1.65M2.44M188.00K
Receivables9.89M6.71M1.65M2.44M188.00K3.00M
Inventory5.92M5.49M
Prepaid Expenses1.94M1.29M1.14M729.00K424.00K2.38M
Restricted Cash338.00K338.00K338.00K5.89M
Total Current Assets164.58M204.91M100.85M55.74M53.10M56.29M
Property, Plant & Equipment14.10M13.88M7.98M7.99M11.07M21.74M
Other Intangible Assets1.38M
Other Long-Term Assets827.00K781.00K96.00K277.00K43.00K168.00K
Total Assets179.51M219.57M108.93M64.00M64.21M79.59M
Accounts Payable2.99M7.89M3.44M1.86M1.81M4.33M
Accrued Expenses7.20M8.47M6.33M5.99M3.99M5.58M
Current Portion of Long-Term Debt13.33M12.22M5.93M
Current Portion of Leases1.28M864.00K823.00K998.00K1.77M1.82M
Current Income Taxes Payable2.00K126.00K
Other Current Liabilities2.00K64.00K4.58M204.00K4.89M
Total Current Liabilities24.81M29.57M16.59M13.42M7.78M16.62M
Long-Term Debt1.66M7.81M13.04M
Long-Term Leases3.60M4.07M3.26M4.40M5.85M7.56M
Long-Term Unearned Revenue677.00K
Other Long-Term Liabilities20.71M18.90M32.01M31.35M23.82M13.04M
Total Liabilities51.45M60.35M64.90M49.18M37.45M37.22M
Common Stock572.00K550.00K457.00K265.00K177.00K1.47M
Additional Paid-In Capital906.91M900.60M856.82M764.15M722.05M696.56M
Retained Earnings-779.34M-742.08M-813.26M-749.52M-695.34M-655.64M
Comprehensive Income & Other-79.00K138.00K8.00K-66.00K-129.00K-27.00K
Shareholders' Equity128.06M159.22M44.03M14.83M26.76M42.37M
Total Liabilities & Equity179.51M219.57M108.93M64.00M64.21M79.59M
Total Debt19.87M24.97M23.05M5.40M7.63M9.38M
Net Cash (Debt)126.95M166.44M74.67M46.83M44.52M35.65M
Net Cash Per Share2.282.521.822.195.669.05
Filing Date Shares Outstanding57.18M57.05M48.53M27.36M17.71M5.90M
Total Common Shares Outstanding57.23M55.04M45.64M26.52M17.72M5.89M
Working Capital139.77M175.34M84.27M42.31M45.32M39.67M
Book Value Per Share2.242.890.960.561.517.20
Tangible Book Value128.06M159.22M44.03M14.83M26.76M40.98M
Tangible Book Value Per Share2.242.890.960.561.516.96
Machinery13.18M12.02M9.98M7.92M9.02M10.98M
Construction In Progress59.00K624.00K3.22M
Leasehold Improvements15.48M15.12M8.80M8.60M8.61M8.60M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-62.89M71.18M-63.73M-54.19M-39.70M-84.94M
Depreciation & Amortization3.68M3.56M2.91M3.20M4.58M4.46M
Loss (Gain) From Sale of Assets-152.37M-2.00K47.00K138.00K
Asset Writedown & Restructuring Costs-1.06M5.66M32.47M
Stock-Based Compensation11.57M10.78M6.63M4.77M3.05M8.92M
Other Operating Activities-725.00K-4.10M2.57M12.02M-11.32M-8.31M
Change in Accounts Receivable-9.39M-6.15M3.00M-3.00M
Change in Inventory-3.23M-5.49M
Change in Accounts Payable-1.10M6.54M1.51M2.04M-4.11M825.00K
Change in Unearned Revenue677.00K
Change in Other Net Operating Assets542.00K-287.00K-5.89M-3.83M-4.78M-16.09M
Operating Cash Flow-76.44M-76.33M-56.02M-37.01M-43.48M-65.67M
Capital Expenditures-5.09M-7.97M-2.45M-331.00K-130.00K-4.15M
Sale of Property, Plant & Equipment18.00K204.00K1.73M
Investment in Securities-29.34M-39.36M-36.81M335.00K-25.57M70.21M
Other Investing Activities152.37M
Investing Cash Flow-34.42M105.03M-39.24M208.00K-23.96M66.06M
Long-Term Debt Issued20.00M
Total Debt Repaid-5.56M
Net Debt Issued (Repaid)-5.56M20.00M
Issuance of Common Stock8.78M26.08M85.63M37.39M46.96M24.03M
Repurchase of Common Stock-5.00K
Other Financing Activities-1.00K-37.00K-1.49M-332.00K831.00K
Financing Cash Flow3.22M26.04M104.14M37.06M43.17M24.86M
Net Cash Flow-107.64M54.74M8.88M256.00K-24.27M25.26M
Free Cash Flow-81.53M-84.30M-58.46M-37.34M-43.61M-69.82M
Free Cash Flow Margin-319.46%-1,448.47%-1,066.86%-3,084.37%-2,327.20%
Free Cash Flow Per Share-1.46-1.27-1.42-1.75-5.55-17.73
Levered Free Cash Flow-73.40M-55.60M-37.88M-18.89M-19.73M-62.58M
Unlevered Free Cash Flow-71.33M-53.26M-35.25M-18.63M-19.27M-60.30M
Cash Interest Paid2.25M2.59M2.67M
Cash Income Tax Paid7.00K14.00K
Change in Working Capital-28.08M-5.39M-4.38M-1.79M-5.89M-18.26M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization248.75M285.59M242.13M124.11M52.90M49.41M
Enterprise Value121.80M102.58M155.54M76.05M43.03M-11.42M
Last Close Price4.355.275.575.013.088.43
PE Ratio4.01
Forward PE231.80
PS Ratio9.7549.0735.4637.4116.47
PB Ratio1.941.795.508.371.981.17
P/TBV Ratio1.941.795.508.371.981.21
EV/Sales Ratio4.7717.6221.7330.43
Debt / Equity Ratio0.150.160.520.360.280.22
Net Debt / Equity Ratio-0.99-1.04-1.70-3.16-1.66-0.84
Net Debt / EBITDA Ratio1.571.921.201.021.060.66
Net Debt / FCF Ratio1.561.971.281.251.020.51
Asset Turnover0.120.040.060.020.03
Quick Ratio6.326.705.994.076.732.89
Current Ratio6.636.936.084.156.833.39
Return on Equity (ROE)-43.13%70.05%-216.57%-260.60%-114.85%-117.22%
Return on Assets (ROA)-24.55%-34.04%-46.41%-46.99%-39.34%-31.07%
Return on Invested Capital (ROIC)-499.52%
Return on Capital Employed (ROCE)-54.00%-47.10%-69.50%-95.30%-80.20%-91.10%
Earnings Yield-27.22%24.93%-26.32%-43.66%-75.04%-171.90%
FCF Yield-32.77%-29.52%-24.14%-30.09%-82.44%-141.30%
Buyback Yield / Dilution1.73%-61.12%-91.99%-171.96%-99.65%-6.24%